January 21, 2016

FPS Pharma Inc. is in default of CSE requirements. Effective at Market Close, FPS Pharma will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective Market Close, January 21, 2016

Symbol: FPS.U

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com